Author:
Lewis Sandy,Wray Sibyl E.,Evans Emily,Romano Carla,Bartolome Lauren,Su Wendy,Shah Roshani,Russo Patricia A.
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Reference18 articles.
1. Kasser SL, Goldstein A, Wood PK, Sibold J. Symptom variability, affect and physical activity in ambulatory persons with multiple sclerosis: understanding patterns and time-bound relationships. Disabil Health J. 2017;10(2):207–13.
2. Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sorensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83(3):278–86.
3. US Food and Drug Administration. Patient-focused drug development: collecting comprehensive and representative input. Guidance for industry, food and drug administration staff, and other stakeholders. 2020. https://www.fda.gov/media/139088/download. Accessed 12 May 2021.
4. Bamer AM, Cetin K, Amtmann D, Bowen JD, Johnson KL. Comparing a self report questionnaire with physician assessment for determining multiple sclerosis clinical disease course: a validation study. Mult Scler. 2007;13(8):1033–7.
5. Bogosian A, Morgan M, Bishop FL, Day F, Moss-Morris R. Adjustment modes in the trajectory of progressive multiple sclerosis: a qualitative study and conceptual model. Psychol Health. 2017;32(3):343–60.